Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.

@article{Hong2013ValidationOA,
  title={Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.},
  author={Christina M. Hong and Shara Kim and Greg Curnew and Sam Schulman and Eleanor Pullenayegum and Anne Holbrook},
  journal={Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharamcologie clinique},
  year={2013},
  volume={20 3},
  pages={
          e229-37
        }
}
BACKGROUND Decision aids have been helpful to support patients in decision-making including anticoagulation. With the introduction of new oral anticoagulants (NOACs), it will be important to assist patients and physicians in shared decision-making about NOACs and warfarin. OBJECTIVES To validate a patient decision aid (DA) for warfarin versus dabigatran, the first NOAC approved for atrial fibrillation (AF). METHODS Participants without AF and not taking anticoagulants were recruited for the… CONTINUE READING
7
Twitter Mentions

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

Effect of the iChoose Kidney decision aid in improving knowledge about treatment options among transplant candidates: A randomized controlled trial.

  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2018

Anticoagulation Management

  • Springer International Publishing
  • 2015